Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) - ANVISA Registration 81285200013

Access comprehensive regulatory information for HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81285200013 and manufactured by FUNDAÇÃO BAIANA DE PESQ. CIENTIFICA E DESENV. TECNOLOGICO, FORNECIMENTO E DISTRIBUIÇÃO DE MEDICAMENTOS-BAHIAFARMA. The registration is held by FUNDAÇÃO BAIANA DE PESQ. CIENTIFICA E DESENV. TECNOLOGICO, FORNECIMENTO E DISTRIBUIÇÃO DE MEDICAMENTOS-BAHIAFARMA with validity until Nov 27, 2027.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81285200013
Registration Details
ANVISA Registration Number: 81285200013
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Registration Details

81285200013

25351321714201774

13078518000190

Dates and Status

Nov 27, 2017

27/11/2027

09/18/2025 19:00:01